masitinib
New research article confirms role of masitinib as a potential pancreatic cancer therapy
February 25, 2021AB Sciences, Cancer, masitinib
A recently published, peer-reviewed research article has concluded that the inhibition of mast cells with AB Science’s masitinib could represent …
AB Science will not seek review of masitinib rejection in Europe
May 29, 2018Manufacturing and Production, Sales and Marketing EMA, Europe, ab science, als, masitinib, pharma
AB Science has U-turned on its pursuit of a do-over on its marketing application of masitinib in Europe after the …
CHMP rejects AB Science’s ALS therapy in Europe
April 23, 2018Sales and Marketing AB Sciences, EMA, European Medicines Agency, ab science, als, masitinib, pharma
AB Science has revealed that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …
New therapy wins EMA orphan drug designation for ALS
August 9, 2016Manufacturing and Production, Research and Development EMA, Ice Bucket Challenge, ab science, als, masitinib, oprhan drug designation
French pharma company AB Science has announced that the European Medicines Agency has granted orphan drug status to masitinib for …
